Optic IconOptic Logo
|
SearchCollectionsBenchmarks

SON-1010

1 abstract

Abstract
SB221: A proof-of-concept study to assess the combination of SON-1010 (IL12-FHAB) and atezolizumab in patients with platinum-resistant ovarian cancer.
Org: Blacktown Cancer and Hematology Centre, Albury Wodonga Cancer Care,